Summit Partners Public Asset Management, LLC Moderna, Inc. Transaction History
Summit Partners Public Asset Management, LLC
- $3.79 Billion
- Q3 2025
A detailed history of Summit Partners Public Asset Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Summit Partners Public Asset Management, LLC holds 30,000 shares of MRNA stock, worth $742,800. This represents 0.18% of its overall portfolio holdings.
Number of Shares
30,000Holding current value
$742,800% of portfolio
0.18%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding MRNA
# of Institutions
844Shares Held
256MCall Options Held
40.8MPut Options Held
46.4M-
Vanguard Group Inc Valley Forge, PA41.6MShares$1.03 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$633 Million0.07% of portfolio
-
Baillie Gifford & CO20.6MShares$510 Million0.45% of portfolio
-
State Street Corp Boston, MA17.1MShares$424 Million0.02% of portfolio
-
Morgan Stanley New York, NY9.96MShares$247 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $9.69B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...